Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03848962 · ClinicalTrials.gov registry record
Collection and Distribution of Biospecimens for Novel Research Uses
A clinical trial of Healthy and Cancer, sponsored by iSpecimen.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 2
- Study locations
NCT03848962: Recruiting study of Healthy and Cancer, sponsored by iSpecimen.
NCT03848962 is a study of Healthy and Cancer that is actively recruiting participants, run by iSpecimen. The registered enrollment target is 10,000 participants, above the 638-participant average among 1,090 other Healthy trials with a reported enrollment target (1467% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03848962, a study of Healthy and Cancer, is actively recruiting participants, sponsored by iSpecimen.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").
Primary Outcome
Repository of diseased and healthy tissue, blood derivatives and related biological specimens
Conditions Studied
Study Locations (2)
Alabama
- iSpecimen - Huntsville
Massachusetts
- iSpecimen - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2016-06-30 |
| Est. Completion | 2026-12-31 |
What NCT03848962 shows while recruiting
NCT03848962 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 638-participant average among 1,090 other Healthy trials with a reported enrollment target (1467% higher).
The record links to 8 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT03848962 reports a single indexed study location in Alabama, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03848962 about?
NCT03848962 is a clinical study titled "Collection and Distribution of Biospecimens for Novel Research Uses". iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnos...
What is the current status of trial NCT03848962?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2016-06-30. Estimated completion is 2026-12-31.
What conditions does trial NCT03848962 study?
This clinical trial studies the following conditions: Healthy, Cancer, Autoimmune Diseases, Infectious Disease, Gastrointestinal Complication.
Who is sponsoring clinical trial NCT03848962?
This trial is sponsored by iSpecimen, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03848962 being conducted?
This trial has 2 study locations across Alabama, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03848962's enrollment target sits among peer trials
10,000 7th of 1090 higher than 1,083 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI